Societe Generale recent bets

Morgan Stanley recent bets

Recent Big Buys

Top deal-making stocks

Most insider traded stocks

Leading investors

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Profitability and efficiency haven't been upto the mark

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Price return has been average, nothing exciting

Financials growth has been moderate for a few years

Showing good signs of profitability & efficiency

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Average profitability - not good, not bad

The Nifty Pharma index closed 0.13 per cent at 21740.10.

Stock market update: Nifty Pharma index 0.13%

The Nifty Pharma index was trading 0.27 per cent at 21826.70.

Stock market update: Nifty Pharma index 0.27% in a weak market

Global pharmaceutical industry must recommit to voluntary licensing and technology transfers to bridge health inequities, says 2024 report.

Global pharma licensing agreements see a slow-down, says report

Indian headline indices ended Tuesday in the green, breaking their seven-session losing streak, aided by gains in auto and pharma stocks. The 30-component BSE Sensex closed the day with a minor uptick, gaining 0.31% or 239 points, at 77,578.38, while the Nifty 50 was up by 64.70 points or 0.28%, at 23,518.50.Commenting on the day’s action, Rupak De, Senior Technical Analyst at LKP Securities, said that Nifty remained volatile throughout the session due to a sudden spike in geopolitical tensions between Russia and Ukraine, causing the index to fall below its 200-day moving average (DMA) once again.“On the technical front, the Nifty managed to hold above its recent low, indicating a potential bullish reversal as long as it does not breach the 23,350 level. Conversely, if the index sustains above the 23,500 level, it could move toward the 23,700–23,800 zone,” De said.Indian stock markets are closed today due to the assembly elections in Maharashtra.Here are 5 stock recommendations for Thursday: Stock Ideas

Market Trading Guide: Tech Mahindra among 5 stock recommendations for Thursday - Stock Ideas

Here’s a lesson from history: For a long-term investor, buying in a correcting market is mostly an opportunity. The operative part, of course, is “long-term investor” – not people who check the value of their portfolio every evening. Also, focus on a sector that is making a comeback. Why? Because when a sector catches the limelight for the first time, valuations are high – and promoters tend to be more optimistic than realistic. In a sector that has gone through a troubled phase and is making a comeback, promoters have learnt their lessons and are more realistic in their expectations – as also in capital allocation. Pharma is one such sector. And there are more reasons to take a closer look at it.

As smog engulfs the street, essential pills for a healthy of portfolio: 5 pharma stocks with an upside potential of up to 39%

The Nifty Pharma index closed 1.04 per cent at 21768.85.

Stock market update: Nifty Pharma index 1.04%

The Nifty Pharma index was trading 0.81 per cent at 21718.55.

Stock market update: Nifty Pharma index 0.81% in an upbeat market

Stocks including Reliance Industries, Hero MotoCorp, Grasim, Sobha, Honasa Consumer, Hindustan Zinc, Glenmark Pharma, Cyient and more will be in the spotlight on Monday, November 18.

Stocks in news: RIL, Hero Moto, Grasim, Delhivery, Honasa, Hindustan Zinc & Glenmark Pharma

The Nifty Pharma index was trading 0.49 per cent at 21644.70.

Stock market update: Nifty Pharma index 0.49% in a weak market

Equity benchmarks slide as Nifty50 falls below 23,400 levels amid global cues, tech and healthcare stock selling pressure.

Nifty sinks below 23,400 as tech, pharma stocks drag; Metals shine

Indian benchmark indices ended with declines on Thursday, marking their fifth consecutive fall. Today’s decline was led by FMCG and pharma stocks, which wiped out earlier morning gains. While the S&P BSE Sensex fell by 110 points, or 0.14%, to close at 77,580, the broader Nifty dropped by 26 points, or 0.11%, to end at 23,532, amid concerns over foreign outflows.Commenting on the day’s action, Rupak De, Senior Technical Analyst at LKP Securities, said that the Nifty closed near its 200-day EMA, forming a gravestone doji-like pattern on the daily chart, signaling bearish sentiment. “This suggests a ‘sell on rise’ approach, as the index hovers in an oversold zone near a key EMA level. A bounce is likely, but it should be seen as an opportunity to sell. If Nifty breaks below the 200-day EMA, selling pressure could intensify. The index has support at 23,450, with resistance expected at 23,650, framing the short-term trading range,” De said.Here are 3 stock recommendations for Monday: Stock Ideas

Market Trading Guide: Bajaj Holdings among top 3 stock recommendations for Monday - Stock Ideas

The ETF tracks Nifty Pharma Index which is designed to reflect the behavior and performance of the pharmaceutical sector in India.